| P/E (FY) | — | Sales (TTM) | $574,245 |
| Earnings (TTM) | -$7.2M | ROE | −142.89% |
| Net Margin | — | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | $1.3M | Trading Days | 5291 |
| 52W High | 27.40 |
| 52W Low | 0.54 |
| % Off High | −97.94% |
| YTD | −79.65% | 1Y | −95.60% |
| 3Y | −99.81% | 5Y | −99.99% |
| 10Y | −100.00% | Since incept. (ann.) | −44.37% |
| Ann. Volatility (1Y) | 156.55% | Ann. Volatility (3Y) | 136.81% |
| Sharpe (1Y) | −1.31 | Sharpe (3Y) | −0.88 |
| Max Drawdown (1Y) | −97.43% | Max Drawdown (3Y) | −99.81% |
| Beta (3Y, vs SPY) | 0.71 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| BJDX | Bluejay Diagnostics, Inc. | $1.0M | — |
| IVF | INVO Fertility, Inc. | $1.8M | — |
| GCTK | Glucotrack, Inc. | $1.9M | 0.0 |
| LYRA | Lyra Therapeutics, Inc. | $887,441 | — |
| TNON | Tenon Medical, Inc. | $2.2M | — |
| BTCY | BIOTRICITY INC. | $2.3M | — |
| VTAK | Catheter Precision, Inc. | $753,892 | — |
| ODYY | Odyssey Health, Inc. | $605,812 | — |
| SSKN | STRATA Skin Sciences, Inc. | $529,938 | — |
| NXGL | NEXGEL, INC. | $4.0M | — |
| PFSA | Profusa, Inc. | $4.8M | — |
| CODX |
| Co-Diagnostics, Inc. |
| $5.1M |
| — |
